Search research articles
Contact Us
Filters
Showing results (141-150 of 434) with videos related to
Page
of 44
Sort By:
Gastroenterology
|
April 10, 2019
Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
Martin L Kårhus, Andreas Brønden, Michael E Røder, et al.
Obesity Surgery
|
February 3, 2011
Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding
Lotte Usinger, Katrine B Hansen, Viggo B Kristiansen, et al.
Diabetes, Obesity & Metabolism
|
December 17, 2011
Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity
Filip K Knop, K Aaboe, T Vilsbøll, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 6, 2018
Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose
Henrik Maagensen, Anders E Junker, Niklas R Jørgensen, et al.
Regulatory Peptides
|
June 29, 2010
Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes
Mikkel Christensen, Filip K Knop, Tina Vilsbøll, et al.
Diabetes
|
February 13, 2010
The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action
Kristine J Hare, Tina Vilsbøll, Meena Asmar, et al.
The Journal of Endocrinology
|
March 10, 2025
The effects of GIP, GLP-1 and GLP-2 on markers of bone turnover: a review of the gut-bone axis
Miriam Longo, David S Mathiesen, Lærke S Gasbjerg, et al.
Diabetologia
|
September 9, 2025
Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations
Vijaya Subramanian, Arthur S Sherman, Jens J Holst, et al.
Diabetes
|
March 16, 2021
Glucagonostatic Potency of GLP-1 in Patients With Type 2 Diabetes, Patients With Type 1 Diabetes, and Healthy Control Subjects
Jonatan I Bagger, Magnus F G Grøndahl, Asger Lund, et al.
Molecular and Cellular Endocrinology
|
March 23, 2025
Exploring the functional, protective, and transcriptomic effects of GIP on cytokine-exposed human pancreatic islets and EndoC-βH5 cells
Kristine Henriksen, Anne Jørgensen, Simranjeet Kaur, et al.
Page
of 44
Search research articles
Search
Showing results (141-150 of 434) with videos related to
Sort By:
Page
of 44
Gastroenterology
|
April 10, 2019
Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
Martin L Kårhus, Andreas Brønden, Michael E Røder, et al.
Obesity Surgery
|
February 3, 2011
Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding
Lotte Usinger, Katrine B Hansen, Viggo B Kristiansen, et al.
Diabetes, Obesity & Metabolism
|
December 17, 2011
Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity
Filip K Knop, K Aaboe, T Vilsbøll, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 6, 2018
Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose
Henrik Maagensen, Anders E Junker, Niklas R Jørgensen, et al.
Regulatory Peptides
|
June 29, 2010
Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes
Mikkel Christensen, Filip K Knop, Tina Vilsbøll, et al.
Diabetes
|
February 13, 2010
The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action
Kristine J Hare, Tina Vilsbøll, Meena Asmar, et al.
The Journal of Endocrinology
|
March 10, 2025
The effects of GIP, GLP-1 and GLP-2 on markers of bone turnover: a review of the gut-bone axis
Miriam Longo, David S Mathiesen, Lærke S Gasbjerg, et al.
Diabetologia
|
September 9, 2025
Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations
Vijaya Subramanian, Arthur S Sherman, Jens J Holst, et al.
Diabetes
|
March 16, 2021
Glucagonostatic Potency of GLP-1 in Patients With Type 2 Diabetes, Patients With Type 1 Diabetes, and Healthy Control Subjects
Jonatan I Bagger, Magnus F G Grøndahl, Asger Lund, et al.
Molecular and Cellular Endocrinology
|
March 23, 2025
Exploring the functional, protective, and transcriptomic effects of GIP on cytokine-exposed human pancreatic islets and EndoC-βH5 cells
Kristine Henriksen, Anne Jørgensen, Simranjeet Kaur, et al.
Page
of 44